185 related articles for article (PubMed ID: 7521963)
1. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
Cuckle HS; Holding S; Jones R
Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963
[TBL] [Abstract][Full Text] [Related]
2. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
[TBL] [Abstract][Full Text] [Related]
3. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
4. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
5. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
6. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
Donalson K; Turner S; Wastell H; Cuckle H
Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
[TBL] [Abstract][Full Text] [Related]
7. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
8. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
Wald NJ; Watt HC; Hackshaw AK
N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
[TBL] [Abstract][Full Text] [Related]
9. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome.
Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P
Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446
[TBL] [Abstract][Full Text] [Related]
10. Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.
Yoshida K; Kuwabara Y; Tanaka T; Onda T; Kudo R; Yamamoto H; Sato A; Yanagida K; Okai T; Sakai M; Takai Y; Uemura H; Hoshi K; Fukada Y; Aono T; Maeda K; Ogita S; Ishiko O; Murata Y; Kanzaki T; Myrick F; Grier RE
J Obstet Gynaecol Res; 2000 Jun; 26(3):171-4. PubMed ID: 10932977
[TBL] [Abstract][Full Text] [Related]
11. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
[TBL] [Abstract][Full Text] [Related]
12. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
Watt HC; Wald NJ; George L
Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Watt HC; George L
Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
[TBL] [Abstract][Full Text] [Related]
15. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
16. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
17. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
Wald NJ; George L; Smith D; Densem JW; Petterson K
Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Nanchahal K; Canick JA; Haddow JE; Knight GJ; Palomaki GE
Br J Obstet Gynaecol; 1988 Apr; 95(4):334-41. PubMed ID: 2454652
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA
Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964
[TBL] [Abstract][Full Text] [Related]
20. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
